Kate Godfrey
Research Associate at Imperial College London’s Centre for Psychedelic Research
Key Impact
Kate Godfrey is notable for contributing to leading human psychedelic research on microdosing, neuroimaging, and neuroplasticity at Imperial College London.
Background & Research
Kate Godfrey completed her PhD in pharmacy at the University of Auckland, where she studied neurological correlates of antidepressant response to brain stimulation treatment. She later moved to Imperial College London’s Centre for Psychedelic Research, where she has worked on EEG and other studies of psychedelics, including microdosed LSD and psilocybin-related research. Her work focuses on the neurobiological mechanisms and potential therapeutic applications of psychedelics, especially measures of neuroplasticity.
Collaboration Network
27 collaborators· click a node to visit their profile
Full network →